{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T18:23:09Z","timestamp":1781029389007,"version":"3.54.1"},"reference-count":49,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Diabetes Sci Technol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>People with diabetes admitted to hospital are at risk of diabetes related complications including hypoglycaemia and diabetic ketoacidosis. Point-of-care (POC) tests undertaken at the patient bedside, for glucose, ketones, and other analytes, are a key component of monitoring people with diabetes, to ensure safety. POC tests implemented with a quality framework are critical to ensuring accuracy and veracity of results and preventing erroneous clinical decision making. POC results can be used for self-management of glucose levels in those well-enough and\/or by healthcare professionals to identify unsafe levels. Connectivity of POC results to electronic health records further offers the possibility of utilising these results proactively to identify patients \u2018at risk\u2019 in real-time and for audit purposes. In this article, the key considerations when implementing POC tests for diabetes in-patient management are reviewed and potential to drive improvements using networked glucose and ketone measurements are discussed. In summary, new advances in POC technology should allow people with diabetes and the teams looking after them whilst in hospital to integrate to provide safe and effective care.<\/jats:p>","DOI":"10.1177\/19322968221137360","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T02:20:59Z","timestamp":1677032459000},"page":"509-516","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["How Can Point-of-Care Technologies Support In-Hospital Diabetes Care?"],"prefix":"10.1177","volume":"17","author":[{"given":"Shivani","family":"Misra","sequence":"first","affiliation":[{"name":"Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"},{"name":"Department of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-3589","authenticated-orcid":false,"given":"Parizad","family":"Avari","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Lumb","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-4735","authenticated-orcid":false,"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-7015","authenticated-orcid":false,"given":"Gerry","family":"Rayman","sequence":"additional","affiliation":[{"name":"Ipswich Diabetes Centre, East Suffolk and North East Essex Foundation Trust, Ipswich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-9579","authenticated-orcid":false,"given":"Ketan","family":"Dhatariya","sequence":"additional","affiliation":[{"name":"Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK"},{"name":"Norwich Medical School, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814538940"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00024677-200302020-00003"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Price CP. Point of care testing. Br Med J. 2001;322(7297):1285-1288.\u2009\u2009http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1120384\/.","DOI":"10.1136\/bmj.322.7297.1285"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1517\/17530051003671556."},{"key":"e_1_3_3_6_2","unstructured":"St John A. The evidence to support point-of-care testing. Clin Biochem Rev. 2010;31(3):111-119. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2924123\/."},{"key":"e_1_3_3_7_2","unstructured":"JBDS 11 Management of adults with diabetes on the haemodialysis unit [Internet]. 2016. https:\/\/abcd.care\/resource\/jbds-11-management-adults-diabetes-haemodialysis-unit."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-015-0582-9."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221137338."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12604"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2016.13.217"},{"key":"e_1_3_3_12_2","doi-asserted-by":"crossref","unstructured":"Taboulet P Haas L Porcher R et al. Urinary acetoacetate or capillary beta-hydroxybutyrate for the diagnosis of ketoacidosis in the Emergency Department setting. Eur J Emerg Med.\u2009\u20092004;11(5):251-258.\u2009\u2009http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15359197.","DOI":"10.1097\/00063110-200410000-00003"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0011."},{"key":"e_1_3_3_14_2","unstructured":"Charles RA Bee YM Eng PH Goh SY. Point-of-care blood ketone testing: screening for diabetic ketoacidosis at the emergency department. Singapore Med J. 2007;48(11):986-989. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17975686."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14788."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.1.137"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1137"},{"issue":"3","key":"e_1_3_3_18_2","first-page":"172","article-title":"Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration","volume":"8","author":"Chiu RW","year":"2002","unstructured":"Chiu RW, Ho CS, Tong SF, Ng KF, Lam CW. Evaluation of a new handheld biosensor for point-of-care testing of whole blood beta-hydroxybutyrate concentration. Hong Kong Med J. 2002;8(3):172-176.","journal-title":"Hong Kong Med J"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.4.500"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01233.x"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2011.00768.x."},{"key":"e_1_3_3_22_2","doi-asserted-by":"crossref","unstructured":"Savage MW Dhatariya KK Kilvert A et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011;28(5):508-515. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21255074.","DOI":"10.1111\/j.1464-5491.2011.03246.x"},{"key":"e_1_3_3_23_2","unstructured":"NEQAS Clinical Chemistry scheme website. https:\/\/ukneqas.org.uk\/learning-resources4\/point-of-care\/ Accessed Dec 15 2022."},{"key":"e_1_3_3_24_2","unstructured":"WEQAS POCT scheme. https:\/\/www.weqas.com\/services\/poct-eqa\/. Accessed Dec 15 2022."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2016-0303"},{"key":"e_1_3_3_26_2","unstructured":"Zhelev Z Peters J Rogers M Andrews R McDonald T Hyde C. Accuracy and validity of HbA1c Point of Care Testing: a review of the scientific evidence and guidelines [Internet]. 2020. https:\/\/www.healthcheck.nhs.uk\/seecmsfile\/?id=1592."},{"key":"e_1_3_3_27_2","doi-asserted-by":"crossref","unstructured":"Magee MF Nassar C. Hemoglobin A1c testing in an emergency department. J Diabetes Sci Technol. 2011;5(6):1437-1443. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22226261.","DOI":"10.1177\/193229681100500615"},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","unstructured":"Gomez-Peralta F Abreu C Andreu-Urioste L et al. Point-of-care capillary HbA1c measurement in the emergency department: a useful tool to detect unrecognized and uncontrolled diabetes. Int J Emerg Med. 2016;9(1):7. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26894895.","DOI":"10.1186\/s12245-016-0107-6"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","unstructured":"Inoue S Egi M Kotani J Morita K. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Crit Care. 2013;17(2):R48. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23506841.","DOI":"10.1186\/cc12567"},{"key":"e_1_3_3_30_2","unstructured":"ISO 15189:2012 Medical laboratories requirements for quality and competence. http:\/\/www.iso.org\/iso\/catalogue_detail?csnumber=56115. Accessed January 22 2016."},{"issue":"5","key":"e_1_3_3_31_2","first-page":"298","article-title":"Point of care testing: regulation and accreditation","volume":"9","author":"Carlson DA.","year":"1996","unstructured":"Carlson DA. Point of care testing: regulation and accreditation. Clin Lab Sci. 1996;9(5):298\u2013302; quiz 303-4.","journal-title":"Clin Lab Sci"},{"key":"e_1_3_3_32_2","first-page":"27","volume-title":"Medical Biosensors for Point of Care (POC) Applications","author":"Misra S","unstructured":"Misra S, Huddy J, Hanna G, Oliver N. Validation and regulation of point of care devices for medical applications. In: Narayan RJ, ed., Medical Biosensors for Point of Care (POC) Applications. Duxford, England: Woodhead Publishing; 2016:27-44."},{"key":"e_1_3_3_33_2","unstructured":"Clinical Laboratory Standards Institute. EP06-A: evaluation of the linearity of quantitative measurement procedures [Internet]. 2003.\u2009\u2009https:\/\/shop.clsi.org\/method-evaluation-documents\/EP06.html."},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","unstructured":"Topic E Nikolac N Panteghini M et al. How to assess the quality of your analytical method. Clin Chem Lab Med. 2015;53(11):1707-1718. https:\/\/www.degruyter.com\/view\/j\/cclm.2015.53.issue-11\/cclm-2015-0869\/cclm-2015-0869.xml.","DOI":"10.1515\/cclm-2015-0869"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","unstructured":"Stavelin A Petersen PH S\u00f8vik U\u00d8 Sandberg S. External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clin Chem. 2013;59(2):363-371. http:\/\/www.clinchem.org\/content\/59\/2\/363.abstract.","DOI":"10.1373\/clinchem.2012.191957"},{"key":"e_1_3_3_36_2","unstructured":"Australian association of clinical biochemists: position statement on PoCT instruments. Accessed December 15 2022.\u2009\u2009https:\/\/www.aacb.asn.au\/AACB\/AACB\/Resources\/Guidelines-and-Position-Statements.aspx?hkey=9aa4a6c0-6aeb-4bc2-a6fc-38074ebab935"},{"key":"e_1_3_3_37_2","unstructured":"Armbruster DA Pry T. Limit of blank limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29(Suppl.\u20091):S49-S52.\u2009\u2009http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2556583\/."},{"key":"e_1_3_3_38_2","unstructured":"UKAS Laboratory Accreditation Standards. Accessed December 15 2022. https:\/\/www.ukas.com\/resources\/publications\/laboratory-accreditation\/"},{"key":"e_1_3_3_39_2","unstructured":"Clinical and Laboratory Standards Institute. EP28-A3C: defining establishing and verifying reference intervals in the clinical laboratory. 2010. Accessed December 15 2022. https:\/\/clsi.org\/media\/1421\/ep28a3c_sample.pdf"},{"key":"e_1_3_3_40_2","unstructured":"ISO 22870:2006 Point-of-care testing (POCT): requirements for quality and competence. 2006. https:\/\/www.iso.org\/standard\/35173.html."},{"key":"e_1_3_3_41_2","unstructured":"International Organization of Standards: 15189:2012 Medical laboratories\u2014requirements for quality and competence. 2012. https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:15189:ed-3:v2:en"},{"key":"e_1_3_3_42_2","unstructured":"Medicines Healthcare products Regulatory Agency. Management and use of IVD point-of-care test devices [Internet]. 2013. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/371800\/In_vitro_diagnostic_point-of-care_test_devices.pdf."},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","unstructured":"Lumb et al. Variation in the current use of technology to support diabetes management in UK hospitals: Results of a survey of healthcare professionals. J Diabetes Sci Technol. https:\/\/doi.org\/10.1177\/19322968231161076.","DOI":"10.1177\/19322968231161076"},{"key":"e_1_3_3_44_2","unstructured":"Getting It Right First Time. Diabetes. 2020. Accessed December 15 2022. https:\/\/www.gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2020\/11\/GIRFT-diabetes-report.pdf"},{"key":"e_1_3_3_45_2","unstructured":"National Diabetes Inpatient Safety Audit [Internet]. 2022. https:\/\/digital.nhs.uk\/data-and-information\/clinical-audits-and-registries\/national-diabetes-inpatient-safety-audit\/information-for-hospitals."},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-1413"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0264"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50247"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001557"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51456"}],"container-title":["Journal of Diabetes Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968221137360","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/19322968221137360","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/19322968221137360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:16:11Z","timestamp":1777400171000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/19322968221137360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1177\/19322968221137360"],"URL":"https:\/\/doi.org\/10.1177\/19322968221137360","relation":{},"ISSN":["1932-2968","1932-2968"],"issn-type":[{"value":"1932-2968","type":"print"},{"value":"1932-2968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}